A new tool could aid in giving high-risk infants the RSV vaccination priority.

Published Date: 22 May 2024

Following the lack of nirsevimab for the prevention of infant respiratory syncytial virus (RSV) lower respiratory tract infections (LRTIs), a new tool may be able to identify newborns who are most at risk of developing serious RSV LRTIs.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Aspirin Fails to Boost Survival in Colorectal Cancer Trial

2.

Do Anatomy Atlases Reflect Social Inequalities?

3.

A higher risk of chemotherapy-induced peripheral neuropathy is associated with a deficiency in vitamin D prior to treatment.

4.

Some triple negative breast cancers might be avoided by longer breastfeeding

5.

Quizartinib Benefit in AML Limited to FLT3-Mutated Subgroup


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot